Exactech Inc (EXAC): James G Binch , director of Exactech Inc sold 600 shares on Jun 3, 2016. The Insider selling transaction was reported by the company on Jun 6, 2016 to the Securities and Exchange Commission. The shares were sold at $24.86 per share for a total value of $14,916.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 26, 2016, Gary J Miller (Executive Vice President, R&D) sold 9,319 shares at $25.10 per share price.On May 11, 2016, Joel C Phillips (EVP/CFO/Treasurer) sold 3,900 shares at $23.13 per share price.Also, On May 9, 2016, James G Binch (director) sold 1,870 shares at $23.00 per share price.On May 5, 2016, Fern Watts (director) sold 2,000 shares at $22.75 per share price.
Shares of Exactech (EXAC) ended Friday, Jun 3, 2016 session in red amid volatile trading. The shares closed down -0.31 points or -1.24% at $24.68 with 47,109 shares getting traded. Post opening the session at $24.86, the shares hit an intraday low of $24.46 and an intraday high of $24.86 and the price vacillated in this range throughout the day. The company has a market cap of $348 M and the number of outstanding shares has been calculated to be 1,40,96,402 shares. The 52-week high of Exactech is $25.35 and the 52-week low is $16.11.
Company has been under the radar of several Street Analysts.Exactech is Upgraded by Robert W. Baird to Outperform and the brokerage firm has raised the Price Target to $ 26 from a previous price target of $21 .Earlier the firm had a rating of Neutral on the company shares. The Rating was issued on Apr 13, 2016.
Exactech Inc. develops manufactures markets distributes and sells orthopedic implant devices related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. The Company’s operating segments are represented by its major product lines: knee implants hip implants biologics and spine extremity implants and other products. Its other products segment includes miscellaneous sales categories such as surgical instruments held for sale bone cement instrument rental fees shipping charges and other implant product lines. The Company manufactures some components of its knee extremity and hip joint replacement systems at its facility in Gainesville Florida. Its joint replacement products are used by orthopedic surgeons to repair or replace joints that have deteriorated as a result of injury or disease. Its spinal implants are used as an adjunct to the fusion of vertebrae in the treatment of spinal disease and deformity.